RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Financials
  4. Cash and cash equivalents

Elevance Health, Inc.ELV

Market cap
$81.1B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 20248,288+12.20%
Dec 31, 20227,387+51.37%
Dec 31, 20214,880-15.00%
Dec 31, 20205,741+16.29%
Dec 31, 20194,937+25.50%
Dec 31, 20183,934+9.01%
Dec 31, 20173,609-11.44%
Dec 31, 20164,075+92.82%
Dec 31, 20152,114-1.78%
Dec 31, 20142,152+36.00%
Dec 31, 20131,582-28.14%
Dec 31, 20112,202+23.08%
Dec 31, 20101,789

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)